Boston Scientific completes sale of Cardiac Surgery and Vascular Surgery businesses
Boston Scientific Corp. announced Monday that it has completed the sale of its Cardiac Surgery and Vascular Surgery businesses to the Getinge Group of Sweden for $750 million in cash.
Boston Scientific Corp. said it gained US approval for a new version of its drug-coated heart stent, a product the company will manufacture itself rather than licensing from a competitor.